American Urological Association (AUA) provides specific recommendations regarding prostate cancer screening, which vary based on age, risk factors, and overall health:
1. Men Younger Than 40 Years: Routine PSA screening is not recommended due to the very low prevalence of prostate cancer in this age group and the potential harms of unnecessary biopsies and treatments.
2. Men Aged 40 to 54 Years: For men who are not at increased risk (e.g., no family history or not of African American descent), routine screening is also not recommended. However, men at higher risk should discuss the possibility of screening with their healthcare provider.
3. Men Aged 55 to 69 Years: The AUA strongly recommends shared decision-making for men in this age group. The decision to screen should be based on a discussion between the patient and physician about the potential benefits and harms of screening. For those who choose to be screened, a screening interval of every two years is generally preferred over annual screening.
4. Men Aged 70 Years and Older: Routine PSA screening is generally not recommended for men aged 70 and older or for those with a life expectancy of less than 10-15 years. This recommendation is based on the lack of evidence showing a benefit from screening in this population, along with the higher risk of harms.
Additionally, the guidelines emphasize the use of risk calculators and additional biomarkers to better assess prostate cancer risk before deciding on further testing, like biopsies or imaging. These tools help to refine the decision-making process, especially in cases where PSA levels are borderline or there are other risk factors at play
https://www.auanet.org/guidelines-and-quality/guidelines/early-detection-of-prostate-cancer-guidelines
https://www.urologytimes.com/view/expert-highlights-aua-guideline-on-prostate-cancer-screening-and-follow-up
https://www.aafp.org/pubs/afp/issues/2014/0115/p137.html

